airbeld by EMBIO Diagnostics Now Available in the Microsoft Azure Marketplace 


Microsoft Azure customers worldwide now gain access to airbeld by EMBIO Diagnostics to take advantage of the scalability, reliability, and agility of Azure to drive application development and shape business strategies.  

NICOSIA, Cyprus — January 4, 2024 EMBIO Diagnostics today announced the availability of airbeld in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. EMBIO Diagnostics customers can now take advantage of the productive and trusted Azure cloud platform, with streamlined deployment and management. 

EMBIO Diagnostics stands at the forefront of innovation, bringing together a wealth of expertise in hardware and software engineering, artificial intelligence (AI), machine learning, and the design and manufacturing of diagnostic devices. Its commitment to excellence is evident in its relentless pursuit of revolutionary solutions that redefine the landscape of technological advancement in various fields and applications.   

EMBIO is proud to introduce airbeld, its latest indoor air quality monitoring. airbeld is an advanced system that provides customers with real-time information about the air they breathe. Harnessing the power of AI, airbeld empowers individuals and organizations to take prompt action and optimize environmental conditions. 

EMBIO understands the critical importance of indoor air quality in maintaining health and well-being. With airbeld, customers gain valuable insights into the composition of their indoor air, allowing them to make informed decisions to minimize health risks and safeguard productivity levels. This state-of-the-art system not only sets a new standard for air quality monitoring but also reflects our unwavering commitment to creating solutions that positively impact lives. 

“We are thrilled that by leveraging the Microsoft Azure Marketplace we are making airbeld easily accessible to a broader audience, empowering organizations to take proactive steps toward maintaining optimal air quality,” said Constantinos Loizou, CEO and co-founder, EMBIO Diagnostics. “This collaboration is a demonstration to our dedication to innovation and our belief in the transformative power of technology to address real-world challenges.”  

“Microsoft welcomes airbeld by EMBIO Diagnostics to Azure Marketplace, where global customers can find, try, and buy from among thousands of partner solutions,” said Jake Zborowski, General Manager, Microsoft Azure Platform at Microsoft Corp. “Azure Marketplace and trusted partners like EMBIO Diagnostics help customers do more with less by increasing efficiency, buying confidently, and spending smarter.”  

The Azure Marketplace is an online market for buying and selling cloud solutions certified to run on Azure. The Azure Marketplace helps connect companies seeking innovative, cloud-based solutions with partners who have developed solutions that are ready to use.   

Learn more about airbeld at its page on the Microsoft Azure Marketplace. 

About EMBIO Diagnostics 

EMBIO Diagnostics is shaping the future of diagnostics by leveraging AI and machine learning. Our innovative products have garnered significant attention in various industries, including healthcare, environmental, food safety, maritime, and research.  

EMBIO has developed two proprietary technological platforms to address the challenges of rapid, reliable, portable, and digital diagnostics. airbeld, with its powerful sensors and AI integration, provides real-time understanding of indoor air pollutants and helps take informed decisions to sustain a healthy and comfortable environment.  

B.EL.D™, or Bio Electric Diagnostics, is a versatile portable electrochemical analyzer system and is one of the few multi-purpose devices available in the market. It serves as a standalone system, employing the potentiometry principle for rapid, reliable detection of organic and inorganic compounds, and finds applications in various environmental, food system, and medical sectors.  

Headquartered in Nicosia, Cyprus, EMBIO Diagnostics operates on a global scale, serving customers across industries and sectors. As a trusted name in technological solutions, EMBIO continues to lead the way in shaping a future where innovation meets impact.